Key statistics
On Thursday, Mirum Pharmaceuticals Inc (MIRM:NMQ) closed at 39.35, -13.00% below its 52-week high of 45.23, set on Aug 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.57 |
---|---|
High | 40.17 |
Low | 38.31 |
Bid | 15.74 |
Offer | 62.95 |
Previous close | 37.90 |
Average volume | 413.39k |
---|---|
Shares outstanding | 47.71m |
Free float | 46.50m |
P/E (TTM) | -- |
Market cap | 1.88bn USD |
EPS (TTM) | -2.40 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
- Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
- Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
More ▼